Seven deaths each due to leukaemia and pancreatic cancer were observed with 3-0 and 4-1 deaths expected. Among the subcohort of men who worked where both average and peak exposure levels were probably highest, however, one death due to pancreatic cancer (0-9 expected) and no deaths due to leukaemia were observed. Four of the seven who died from leukaemia and six of the seven who died from pancreatic cancer had been assigned to the chlorohydrin department where the potential for exposure to EO is judged to have been low. The relative risk of death due to each disease was strongly related to duration of assignments to that department. When men who worked in the chlorohydrin department were excluded, there was no evidence for an association of exposure to EO with pancreatic cancer or leukaemia. Together with the failure to show independent EO associations, the chlorohydrin department results suggest that leukaemia and pancreatic cancer may have
H L Greenberg, M G Ott, R E Shore Abstract A retrospective cohort study was conducted to examine the mortality experience of 2174 men employed between 1940 and 1978 by a large chemical company and who had been assigned to a chemical production department that used or produced ethylene oxide (EO). Comparisons were made with the general United States population, the regional population, and with a group of 26 965 unexposed men from the same plants. Comparisons with general United States death rates showed fewer deaths than expected in the EO group due to all causes and for total cancers. There was no statisticaily significant excess of deaths due to any cause. Seven deaths each due to leukaemia and pancreatic cancer were observed with 3-0 and 4-1 deaths expected. Among the subcohort of men who worked where both average and peak exposure levels were probably highest, however, one death due to pancreatic cancer (0-9 expected) and no deaths due to leukaemia were observed. Four of the seven who died from leukaemia and six of the seven who died from pancreatic cancer had been assigned to the chlorohydrin department where the potential for exposure to EO is judged to have been low. The relative risk of death due to each disease was strongly related to duration of assignments to that department. When men who worked in the chlorohydrin department were excluded, there was no evidence for an association of exposure to EO with pancreatic cancer or leukaemia. Together with the failure to show independent EO associations, the chlorohydrin department results suggest Because EO is flammable and highly reactive, process equipment in the manufacturing setting generally consists of tightly closed and highly automated systems. Currently, during routine operation, workers have minimal opportunity for exposure and levels in chemical manufacturing plants are typically low, usually less than 1 ppm, the current eight hour time weighted average (TWA8) standard. 2 Historical exposure levels are known to have been higher, however. In industries that use EO for sterilisation, the control of employee exposures may be more difficult due to the greater potential for workers to have physical contact with EO gas.
EO has been shown to be an alkylating agent, which may react directly (and irreversibly) with nucleophilic macromolecules ( '6 A detailed historical reconstruction of chemical processing at the two production facilities had been produced by veteran manufacturing personnel who reviewed available records and prepared chronological listings of substances present in each chemical processing department as far back as 1925.1' Each production department was described in terms of start up and shut down dates and included an inventory of chemicals used and produced.
Work history records of all employees in the base file were searched and individuals were identified who had ever been assigned by 1979 to a chemical production department that was judged to have used or produced EO (study departments). Records of identified employees were further examined to ensure that their inclusion in the cohort was based on assignment during a period when EO was handled.
Study members were not included based on maintenance assignments to EO departments, since their work history records did not typically provide department specific information. Eligible study subjects, however, may have also been assigned to maintenance jobs at some point in their employment. Three EO exposure levels were defined. EO production departments with one or more continuously operating EO converters and recovery systems were considered to have the highest potential for EO exposure, as a result of routine activities such as frequent sampling, maintenance of cycle machines, and EO compressors. Departments using EO were considered to be in the intermediate level if: (1) EO was routinely in use in systems that were indoors in the same building as the operators and there was no pressurised control room, (2) the department was developmental or the process tended to lose EO during routine operations, or (3) the department also produced EO but did not have its own recovery system and therefore was not considered to be a high exposure department. Remaining departments using EO were considered to have the lowest potential for exposure and were assigned to the low exposure category. Significant deficits were seen for deaths due to diseases of the respiratory system and suicide. Nonsignificantly raised SMRs were observed for deaths due to brain cancer, leukaemia, liver cancer, and cancer of the pancreas. Using regional rates, the mortality patterns ofthe study group were essentially unchanged, suggesting that regional factors were relatively unimportant.
Mortality patterns for the subcohort assigned to study departments for at least two years were similar to those of the full cohort. To focus on those men with the greatest potential for exposure, the remaining SMR tables are restricted to this subcohort. Only six of the 211 observed deaths in the subcohort were observed among men who were hired into salaried jobs. Consequently, the mortality patterns of the total subcohort primarily reflect the experience of the hourly subset. malignancies, which were attributable to an excess of leukaemia. There were non-significantly raised SMRs for cancer of the brain and non-Hodgkin's lymphoma. Additional analyses performed to pinpoint a more specific subcohort from which these excesses arose identified the group of men who had been assigned to the chlorohydrin department. Table 5 shows the results of the SMR analysis of this group. Statistically significant excess mortality was observed for pancreatic cancer (6 obs/0 7 exp) and leukaemia (3 obs/04 exp). For the remainder of the cohort never assigned to the chlorohydrin department, there was one death from pancreatic cancer (2 2 exp) and three from leukaemia (1 5 exp). These findings were supported by trends with duration of assignment to the chlorohydrin department (table 6) . Compared with the non-EO group, the relative risks for pancreatic cancer and leukaemia were 14 and 8 7-fold, respectively, for those with 10 or more years of chlorohydrin department assignments. Lagged analyses by duration of chlorohydrin assignments performed for these diseases showed trends that grew steeper and remained highly significant as the assumed induction period increased from 0 to 20 years. No trends for mortality due to either stomach or brain cancer were observed with duration in all study departments or specifically in the chlorohydrin department. tRelative risk estimates using the non-exposed level as baseline. Expected deaths are adjusted for age, calendar period, and interval since hire. Study departments were ranked according to relative potential for exposure according to the nature of their routine production practices determined using the best available evidence. Medical records ofacute exposures to EO support the ranking scheme with respect to the frequency of inhalation and dermal exposures. The ranking scheme is also supported by industrial hygiene surveys of these and other UCC facilities. Based on estimates of operators' TWA8 EO exposures at the UCC Texas City, Texas, plant, exposure levels in direct oxidation EO production were probably in the range of [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] ppm.24 Levels in EO production using the chlorohydrin process were probably somewhat higher, since (1) the technology, construction materials, and work practices were from an earlier era, (2) there was no control room, and (3) the production equipment was indoors. Based on breathing zone samples collected from 1976 to 1978 at the South Charleston and Institute plants, continuous exposure levels in departments using EO were in the order of < 1-3 ppm (possibly an order of magnitude lower than those in production departments).
There were no observed associations of stomach or brain cancer mortality with duration of assignments to study departments. In addition, the risk of death due to leukaemia was not raised in the subcohort exposed to the highest EO levels or in the entire cohort after removal of the chlorohydrin group. Supplementary analyses by level of "integral EO exposure" (level of exposure (high=3, intermediate = 2, low = 1) x duration) were also conducted and yielded similar results. The relative risks of both leukaemia and pancreatic cancer, however, were shown to be strongly associated with duration of assignment to the chlorohydrin department, even after the incorporation of appropriate latent intervals.
Results of proportional hazards modelling were consistent with those ofthe categorical analyses.25 No index of EO exposure was statistically significant when present in a model containing a term for chlorohydrin department duration, whereas the chlorohydrin duration variable was highly significant and remained so for all induction periods examined (0, 5, 10, and 20 years). The chlorohydrin department started up in November 1925. Until September 1931 the department produced ethylene chlorohydrin exclusively. The crude ethylene chlorohydrin was pumped to the EO production department and used for EO production (chlorohydrin process). After that time, three of the seven reaction towers were made available for "special production" of propylene chlorohydrin until sometime between the late 1930s and early 1940s. The equipment was then infrequently used to manufacture bis-chloroethyl ether (BCEE) and dichloroethane or concentrated ethylene chlorohydrin. Both processes used EO and according to the best available information, they were run only sporadically and production volumes were small. These processes represented the sole uses of EO in the chlorohydrin department. The only other opportunity for exposure to EO was the result of fugitive emissions from other EO departments in the same building. Ethylene chlorohydrin production ceased in 1957.
Four of the seven leukaemia decedents and six of the seven pancreatic cancer decedents in the EO cohort had been assigned to the chlorohydrin department. All four leukaemia decedents were first assigned in the 1930s. The six men in the chlorohydrin subcohort who died of pancreatic cancer were first assigned to the department before 1945. Nine of the 10 decedents with leukaemia and pancreatic cancer worked in the chlorohydrin department between 1935 and 1945 and only three of the ten had additional work experience in that department after ethylene chlorohydrin production ceased.
Because the chlorohydrin department had been operating for over 15 years by the beginning of study follow up, there was ample opportunity for selection out of the cohort. Given the distribution of deaths by chlorohydrin duration and that selection out was most likely among men with shorter assignments, it is unlikely that bias could have artificially created the observed trends with duration of chlorohydrin assignments.
The conditions of EO use in the chlorohydrin department were probably not unique, as ad hoc small volume "special production" occurred in many study departments. Thus the possibility that the chlorohydrin results were due to any special circumstances of exposure to EO in that department seems remote. The relative risk of leukaemia (and pancreatic cancer) mortality was found not to be associated with assignment to EO production units or with duration or "integral EO exposure" among the 1896 men in the cohort never assigned to the chlorohydrin department. Inferences from the results in this subgroup to similarly exposed groups are limited by the small cohort size. This is partially offset by the long average period of observation (almost 20 years). Omitting the chlorohydrin subcohort from the total study population and allowing for a latency period (time from first EO related assignment) of ten years, the leukaemia SMR was 65
(1 obs/1-5 exp, 95% CL=3, 310) or 140 (3 obs/2 1 exp, 95 % CL = 27, 409) if the latency requirement is dropped.
During the relevant period, the opportunity for exposure in the chlorohydrin department was greatest for substances related to the production of ethylene chlorohydrin, including the byproducts, dichloroethane and BCEE. Ethylene chlorohydrin has not been found to be carcinogenic when administered to rats by gavage or by dermal application to rats or mice.2627 It was only inconsistently carcinogenic by subcutaneous injection.26 28 On the other hand, the carcinogenicity of dichloroethane has been shown in rats and mice of both sexes. 29 The three cases from the Gardner study did not occur among men assigned to EO production (by either process). Nor did these individuals work in ethylene chlorohydrin production.
In the present study no deaths from leukaemia were observed among men assigned to EO production. With the exception of ingestion of the reaction mixture, the exposure conditions described by Hogstedt et 
